Investment Rating - The report initiates coverage with a "Buy" rating for the company, Kefu Medical [9][13][141]. Core Insights - Kefu Medical, established in 2009, specializes in the research, production, sales, and service of medical devices, covering five major areas: health monitoring, rehabilitation aids, respiratory support, medical care, and traditional Chinese medicine therapy [8][31]. - The company has shown a steady recovery post-COVID, with a 3% year-on-year revenue increase in the first half of 2024, excluding protective products, regular product revenue grew over 20% [8][42]. - The report forecasts revenue growth for 2024-2026 at 31.81 billion, 38.31 billion, and 45.47 billion yuan, with net profits of 3.60 billion, 4.57 billion, and 5.59 billion yuan respectively, indicating a strong growth trajectory [9][135]. Summary by Sections Company Overview - Kefu Medical has a diverse product line and has been focusing on enhancing its R&D capabilities and expanding sales channels to maintain its competitive edge [31][95]. - The company has a relatively concentrated ownership structure, with significant stakes held by its founders [31][42]. Financial Performance - In 2023, Kefu Medical reported revenues of 28.54 billion yuan, a 4% decline due to high base effects from 2022, but with a compound annual growth rate (CAGR) of 18% from 2019 to 2023 [42][147]. - The company expects to enter a long-term growth phase as the impacts of COVID-19 diminish [42][135]. Business Segments - Rehabilitation aids are the largest revenue contributor, accounting for 27% of total revenue in 2023, followed by medical care (26%), health monitoring (21%), and respiratory support (16%) [45][149]. - The report highlights the potential for growth in the hearing aid segment, with the company operating 814 stores under the "Jianer" brand, which has shown a 33.48% revenue increase in the first half of 2024 [128][131]. Market Position and Strategy - Kefu Medical has established a robust online and offline sales network, leveraging major e-commerce platforms and a significant number of physical stores to enhance market penetration [7][65]. - The company is actively expanding its interest e-commerce initiatives, which have seen a 200% revenue increase in 2023 [65][94]. Valuation - The report estimates a reasonable market value of 9.4 billion yuan for Kefu Medical, suggesting a potential upside of approximately 21% from its market capitalization as of November 26, 2024 [9][141].
可孚医疗：家用器械渠道能力突出，看好听力验配高成长潜力